June

Insights on Prescribing and Dispensing Controlled Substances

Three in-person options from 6 - 9pm

June 24, 2025 - Mobile, AL 

July 29, 2025 - Auburn, AL 

August 19, 2025 - Huntsville, AL 

There are numerous state and federal laws/regulations related to controlled substances. These can be confusing to prescribers and dispensers. This program aims to provide clarification regarding those rules and regulations as well as best practices.

July

2025 Consultant Update - Medication Management for the Older Adult-  Live Webinar - July 12, 2025

**The 4-hour program is for pharmacists only who already have their Consultant license** 

This program will focus on disease states and medications that impact the older adult. The 4-hour program will be hosted via Zoom webinar. All 4 hours of programming are approved by the Alabama Board of Pharmacy for consultant credit hours as well as ACPE credit hours.

2025 Consultant Certification: Medication Management for the Older Adult -Live Webinar- July 11 & July 12, 2025

2025 APhA Pharmacy-Based Immunization Delivery Certificate Training Program - Pharmacists

August 1, 2025, 8:00 am - 5:00 pm CT

APhA’s Pharmacy-Based Immunization Delivery certificate training program is based on national educational standards for immunization training from the CDC. This practice-based curriculum represents a fusion of science and clinical pharmacy. The program, which emphasizes a health care team approach, seeks to foster the implementation of interventions that will promote disease prevention and public health. The purpose of this certificate training program is to prepare pharmacists and pharmacy students with comprehensive knowledge, skills, and resources necessary to provide immunization services to patients across the life span. It is comprised of a 12-hour home-study and an 8-hour live seminar, this program provides a total of 20-hours of CPE credit for pharmacists.

This certificate training program is made up of three components – the 12hr self-study, the 8hr live training, and the post live activity.

Featured On-Demand Programs

Understanding Federal Pharmacy Law

This CE presentation reviews federal pharmacy laws, rules, and regulations important for a pharmacist to know and for review of the MPJE.

Understanding Pharmacy Laws and Rules Governing the Health System and Hospitals in Alabama

This CE presentation reviews Alabama-Specific pharmacy laws, rules, and regulations relevant to health-system and hospital settings which are important for a pharmacist to know and for review of the MPJE.

Recorded 2025 LIVE @ LUNCH - When Sleep Goes Wrong: Understanding Insomnia and Narcolepsy

This presentation will provide an update on the management of sleep disorders, specifically insomnia and narcolepsy. Sleep disorders have bi-directional relationships with many other co-occurring conditions; they may both impact and be impacted by these co-occurring conditions and related pharmacotherapy. Management approaches are limited overall and become more limited when considering certain patient specific variables.

Recorded - The Efficacy, Safety, and Overuse of Ceftriaxone: An Antimicrobial Stewardship Discussion 

Recorded - A Practical Approach to PDMP Usage: A Townhall Event

An interactive, 2-hour training session regarding PDMP Usage. Practical application across healthcare professionals with targeted content around common prescribing errors, account maintenance, understanding of prescriber, and patient reports.

Introduction to Antimicrobial Stewardship

This presentation will explore the concept of antimicrobial stewardship, emphasizing its clinical relevance and importance. Participants will be able to identify the Center for Disease Control (CDC)’s Core Elements of antimicrobial stewardship, discuss strategies to improve inappropriate antibiotic use, and review resources available to assist healthcare professionals with clinical decision-making related to antibiotics. The session will be interactive, featuring case vignettes to enhance learning and application.

National Regulatory Requirements for Antibiotic Stewardship in Acute Care Hospitals

Antibiotic Stewardship is required for acute care hospitals participating in the Center for Medicaid/Medicare reimbursement programs and for those seeking/maintaining Joint Commission accreditation status. This program will provide a comprehensive review of these guidelines and provide updates regarding recent changes.

Bugs & Drugs: An Antimicrobial Agents Review

The cornerstone of antimicrobial stewardship is the correct use of antimicrobial agents.  In order to use antimicrobial agents correctly, clinicians must be familiar with the drugs themselves, including their spectrum activity, mechanisms of action, adverse effect profile, and major drug interactions. Additionally, multiple new agents have been brought to the market in recent years, and clinicians must be aware of where these new agents fit into clinical practice. This presentation will provide a comprehensive review of current antimicrobials on the market, with a particular focus on their spectrums of activity and use in clinical practice.   

Treatment of Community-Acquired Pneumonia

This presentation will review the diagnosis and recommended treatment of community acquired pneumonia for all practice settings as well as treatment considerations when selecting appropriate therapy. Furthermore, strategies to promote antimicrobial stewardship in the treatment of community acquired pneumonia will be discussed.

Treatment of Skin and Soft Tissue Infections (SSTIs), Diabetes-related Foot Infections (DFIs) and Osteomyelitis

Skin and soft tissues infections, diabetes-related foot infections, and osteomyelitis are frequently occurring infections among patients in both the inpatient and outpatient settings. Appropriate classification of these infections and recognition of the corresponding common causative pathogen are essential to determine optimal empiric antimicrobial therapy. This presentation will review types of SSTI and osteomyelitis along with common pathogens and discuss aspects of antimicrobial therapy for treatment of SSTI and osteomyelitis, including dosing, route, monitoring parameters and duration. Key recommendations for the treatment of diabetes-related foot infections from the most recent 2023 IWGDF/IDSA guidelines will also be included to provide contemporary evidence to attendees.

Treatment of Urinary Tract Infections

Urinary tract infections (UTIs) are one of the most common indications for receipt of antimicrobial therapy in both the community, hospital, and long-term care settings.  However, inappropriate use of broad-spectrum antibiotics for the treatment of UTIs has significantly contributed to the development of antimicrobial resistance to UTI pathogens. Therefore, clinicians must understand the appropriate treatment of UTIs to not only treat the diseases, but also minimize the development of antimicrobial resistance.  This program will focus on the appropriate treatment of different types of UTIs, including acute cystitis, pyelonephritis, catheter-associated UTIs, complicated UTIs, and pyelonephritis. 

Treatment of Clostridioides difficile Infection

This program will describe the risk factors associated with C. difficile infection (CID) and will focus on the current recommended treatment options, both pharmacotherapy and non-pharmacotherapy.  Additionally, the program will discuss new options that have recently come to the market for the treatment and prevention of CDI.

Antimicrobial Stewardship in the Intensive Care Unit 

This presentation focuses on the critical role of antimicrobial stewardship (AMS) in the Intensive Care Unit (ICU), where patients are highly susceptible to infections and often exposed to broad spectrum antibiotics. Pharmacists play a key role in implementing AMS strategies to optimize antimicrobial use, reduce resistance, and improve patient outcomes.

Sepsis Stewardship: Treatment of Sepsis and Septic Shock

This presentation will discuss the treatment of sepsis and septic shock. It will discuss how to prioritize treatment choices, practical logistic needs and applications, and how to de-escalate therapy as the patient recovers.

The Treatment of Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP)

This is part of the CE programming on Improving Antimicrobial Stewardship Across Alabama (IASAA). Specifically this CE will evaluate the treatment of HAP and VAP.

Recorded New Drug Update 2024

The presentation will provide an update on new drugs approved by the FDA over the past calendar year

Recorded Sterile Compounding Review for ALBOP Recertification 2024

This 2-hour CE is on the topic of sterile compounding of nonhazardous and hazardous drugs and aims to fulfill the requirements for the Alabama State Board of Pharmacy for recertification for pharmacists involved in parenteral compounding.

This program has been approved by the ALBOP for continuing education didactic renewal requirements for pharmacists certified in sterile compounding. To fully comply with the ALBOP sterile compounding renewal requirements for both didactic and practical components, participants must complete their practical component outside of this program offering. Results from fingertip/ media fill tests will fulfill the practical component requirement.

Recorded LIVE @ LUNCH - OTC Update: Combatting Cough & Cold Symptoms 

This webinar will focus on nonprescription medications used for self-care of cough and cold symptoms. The presentation will start with an overview of the symptoms of cough and cold, exclusions for self-care, and common treatment strategies. With each treatment strategy, evidence related to safety and efficacy will be presented with a focus on recent efficacy concerns and potential OTC medications of misuse. The presentation will conclude with a review of the steps in the QuEST process and application to a patient case scenario.

Recorded Fostering Inclusive Excellence in Pharmacy Preceptorship

This session will explore the impact of legislative changes and accreditation standards on inclusive excellence initiatives in pharmacy education. Participants will learn about the importance of cultural competence, the challenges to achieving inclusive excellence, and the benefits of inclusive practices. Discover best practices for preceptors to promote an inclusive and equitable learning environment in both classroom and clinical settings. 

Recorded Stay Ahead: Immunization Insights for 2024

Pharmacists who administer vaccines are required to have continuing education on the topic. In Alabama 2 hours is needed every renewal cycle. 

This presentation summarizes the current immunization recommendations from the ACIP for pediatric and adult populations. Immunization recommendations are updated three times a year by ACIP, and pharmacists must remain up-to-date with this information for patient care. This presentation will review how to determine what vaccines a patient needs, provide an update on immunization requirements, and discuss best practices and techniques for administering vaccines.

This program has been approved by the Alabama Board of Pharmacy for continuing education credit to meet Immunization renewal licensure requirements. 

Recorded 2024 PRECEPTOR DEVELOPMENT WEBINAR 

This preceptor development program was developed to educate and assist preceptors with effective precepting techniques, understanding statutes and rules for preceptors in the state of AL, inclusive excellence information relating to precepting, and dealing with the disengaged/unmotivated student. Engaging material will include interactive lectures, real-world examples, and a panel discussion.

This program has been approved by the Alabama Board of Pharmacy for continuing education credit to meet Preceptor licensure requirements. 

Alabama's Prescription Drug Monitoring Program: The Essentials

Correct and complete prescription information is essential to the integrity of the controlled substance database. Incomplete or inaccurate prescription information can result in prescriptions not being transmitted to the controlled substance database, which can cause inaccurate patient records, complications between prescribers and their regulatory boards, and a diminished clinical tool for healthcare providers.